An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Conditions
Plaque Psoriasis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Oruka Therapeutics Investigative Site, Fountain Valley, California, United States
Oruka Therapeutics Investigative Site, Los Angeles, California, United States
Oruka Therapeutics Investigative Site, San Diego, California, United States
Oruka Therapeutics Investigative Site, Santa Ana, California, United States
Oruka Therapeutics Investigative Site, Santa Monica, California, United States
Oruka Therapeutics Investigative Site, Cromwell, Connecticut, United States
Oruka Therapeutics Investigative Site, Miami, Florida, United States
Oruka Therapeutics Investigative Site, Rolling Meadows, Illinois, United States
Oruka Therapeutics Investigative Site, Bowling Green, Kentucky, United States
Oruka Therapeutics Investigative Site, Rockville, Maryland, United States
Oruka Therapeutics Investigative Site, Boston, Massachusetts, United States
Oruka Therapeutics Investigative Site, Detroit, Michigan, United States
Oruka Therapeutics Investigative Site, New York, New York, United States
Oruka Therapeutics Investigative Site, New York, New York, United States
Oruka Therapeutics Investigative Site, Portland, Oregon, United States
Oruka Therapeutics Investigative Site, Norfolk, Virginia, United States
Oruka Therapeutics Investigative Site, Edmonton, Alberta, Canada
Oruka Therapeutics Investigative Site, Edmonton, Alberta, Canada
Oruka Therapeutics Investigative Site, Surrey, British Columbia, Canada
Oruka Therapeutics Investigative Site, London, Ontario, Canada
Oruka Therapeutics Investigative Site, Markham, Ontario, Canada
Oruka Therapeutics Investigative Site, Peterborough, Ontario, Canada
Oruka Therapeutics Investigative Site, Toronto, Ontario, Canada
Oruka Therapeutics Investigative Site, Waterloo, Ontario, Canada